SUPPORTING INNOVATION TO ENHANCE FUTURE CARE IN PBC

View On IPO.GOV.AU

Registered: Registered/protected

Last updated on 14 Jul 2016

Owner Info

Intercept Pharmaceuticals, Inc. a corporation of the State of Delaware

450 W. 15th Street, Suite 505

New York New York 10011, UNITED STATES OF AMERICA

Serial Number

1725644 filed on 2 Oct 2015

Correspondent

Gorton IP

GPO Box 629,

SYDNEY, NSW, 2001 AUSTRALIA,

SUPPORTING INNOVATION TO ENHANCE FUTURE CARE IN PBC

Classification Information

1725644

2 Oct 2015

2 Oct 2025

WORD

1 Oct 2015

Status Date	Action Taken
14^th Jul 2016	IP Right Registration Published
8^th Jul 2016	Register Trade Mark
7^th Jul 2016	Registration fee (1 class)
3^rd May 2016	Application Status
25^th Feb 2016	IP Right Acceptance Published
15^th Feb 2016	Amend Status from Awaiting Advertisement
13^th Jan 2016	Application Accepted correspondence sent
13^th Jan 2016	Clear Examination report approved
13^th Jan 2016	Goods and Services Classes
13^th Jan 2016	Goods and Services description amendment